Mumbai, September 16, 2026: HCG Cancer Hospital, Colaba and Asian Cancer Institute (ACI) – Cumballa Hill Hospital announced a strategic collaboration aimed at strengthening access to world-class, comprehensive and integrated cancer care for patients across Mumbai and beyond. As part of this collaboration, the institutes will be leveraging their expertise and capabilities to develop an integrated model of cancer care.
Speaking on the announcement, Dr. B.S. Ajaikumar, Non-Executive Chairman, HealthCare Global Enterprises Limited, said, “At HCG, we have always believed in ‘adding life to years’ as one of our key philosophies when approaching cancer treatment. Throughout the years, we have always strived to utilize sophisticated technology and provide access to the best treatments for patients. Through this partnership, we are aiming to simplify the cancer journey for patients by reducing fragmentation between different stages of treatment and ensuring greater coordination among specialists.”
Sharing further insights on the collaboration, Dr. Ramakant Deshpande, Executive Chairman, Asian Cancer Institute said, “Our objective is very clear — to provide world-class comprehensive cancer treatment with the patient at the centre of everything we do. This collaboration brings together complementary strengths to create a stronger, more integrated cancer-care platform in Mumbai. We want patients to have access to the right expertise, technology and treatment pathways in a coordinated manner, with quality and compassion as the guiding principles.”
Through this collaboration, HCG Cancer Hospital and ACI Cumballa Hill Hospital intend to leverage their respective clinical capabilities, infrastructure, technology and professional expertise. It will focus on comprehensive multidisciplinary cancer treatment, integrated cancer diagnosis and treatment planning, advanced surgical, medical and radiation oncology services Multidisciplinary Tumour Board-based decision making, advanced diagnostics and pathology support, precision and personalized cancer treatment approaches as well as improved access to advanced cancer technologies. Apart from this, the collaboration will also focus on patient navigation and coordinated care pathways, supportive, palliative and survivorship care, clinical quality, safety and outcome improvement as well as academic, training and knowledge-sharing initiatives.
Speaking on this strategic collaboration, Dr. Manish Mattoo, Executive Director and CEO, HealthCare Global Enterprises Limited said, “Cancer treatment today requires more than individual clinical interventions. It demands multidisciplinary expertise, advanced technology, evidence-based protocols and seamless coordination across specialties. Through this partnership, patients will benefit from a model where clinical expertise, technology and hospital infrastructure come together around the individual patient’s needs, rather than requiring the patient to navigate a complex healthcare system independently.”
With its strategic location in South Mumbai, HCG Cancer Hospital along with ACI Cumballa Hill Hospital are well positioned to provide access to world class cancer care treatments. The institutes are planning to further expand their depth and knowledge in specialized oncology services to cater to the patient’s needs.
“The partnership is designed to create a seamless continuum of cancer care spanning early diagnosis, multidisciplinary evaluation, surgical oncology, medical oncology, radiation oncology, advanced diagnostics, supportive care, rehabilitation and survivorship, enabling patients and their families to access the right treatment at the right time,” Mr. Rupesh Choubey, Vice President – Regional COO, Maharashtra & MP, HCG Cancer Hospital added.
Both the institutions will be working towards establishing standardised clinical pathways, multidisciplinary collaboration and continuous quality improvement, with the goal of delivering outcomes aligned with global standards of cancer care. It will progressively explore opportunities to expand cancer services, strengthen specialist networks, introduce advanced treatment capabilities and develop programmes that address the changing needs of cancer patients in Mumbai and the wider region.